Outcome of the Meeting of the Board of Directors of Welcure Drugs And Pharmaceuticals Limited held today i.e. Monday, December 01, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Welcure Drugs & Pharmaceuticals met on December 1, 2025, and approved raising up to Rs. 49 Crores through a Rights Issue of equity shares (face value Rs. 1.00 each) to existing shareholders, with the price and entitlement ratio to be decided later. The Board also approved the Draft Letter of Offer for filing with BSE and constituted a Rights Issue Committee chaired by Managing Director Chintan Didawala Ganpat, with Bhumika Pradhan and Yogeshkumar Prajapati as members. Separately, the Board accepted the resignation of Non-Executive Independent Director Mr. Pradeep Dnyaneshwar Terse (DIN: 10758084), effective December 1, 2025, citing pre-occupation with other matters. The meeting lasted from 11:00 AM to 11:35 AM.
Eligible shareholders will get an opportunity to subscribe to additional equity shares through the Rights Issue, which could lead to dilution if they do not participate. The fund raise of up to Rs. 49 Crores signals capital infusion for the company, while the sudden exit of an Independent Director within a few months of his appointment (DIN registered November 2024) may raise minor governance questions among investors.